RxDoctor Payments DataLook up a doctor →

Enhertu: payments to doctors

Payments that named Enhertu as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$20.8M
Providers
19,434
Transactions
131,429
Average per transaction
$158

The per-transaction average — $158 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 19,434 providers the average total is $1,070, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Daiichi Sankyo Inc.$13,638,05765.6%
AstraZeneca$6,659,89532.0%
Astrazeneca UK Limited$259,7591.2%
Daiichi Sankyo Company LTD$218,4861.1%
Daiichi Sankyo Europe GmbH$20,7580.1%
← All drugs & devices